#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

byTeddy Guo

July 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

RelatedReports

#VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer

StudyGraphics

#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma

May 19, 2022

Dacomitinib may be effective in EGFR-associated lung cancer

Chronic Disease

Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer

May 9, 2022

#VisualAbstract: Aromatase inhibitors significantly reduce recurrence in premenopausal women with ER+ breast cancer and ovarian suppression

StudyGraphics

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

May 4, 2022

#VisualAbstract: Ruxolitinib use may be associated with higher incidences of nonmelanoma skin cancers

StudyGraphics

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

April 27, 2022

Celiac disease more prevalent in children with irritable bowel syndrome

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

Incidental findings common with breast imaging, often benign

Tamoxifen decreases recurrence rates at 25 years in lymph node-negative estrogen-receptor-positive and Erb-B2 Receptor Tyrosine Kinase 2-negative breast cancer

Active smoking cessation intervention may provide tangible results [Project CLIQ]

Systematic analysis of tobacco smoking prevalence in 204 countries from 1990 to 2019

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma

Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

RelatedReports

#VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma

Neoadjuvant nivolumab improves survival in patients with resectable non-small cell lung cancer

#VisualAbstract: Upper neck irradiation is noninferior to whole neck irradiation for newly diagnosed nasopharyngeal carcinoma

#VisualAbstract: Trastuzumab does not improve survival in patients with esophageal adenocarcinoma with HER2 overexpression

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

Tamoxifen decreases recurrence rates at 25 years in lymph node-negative estrogen-receptor-positive and Erb-B2 Receptor Tyrosine Kinase 2-negative breast cancer

Systematic analysis of tobacco smoking prevalence in 204 countries from 1990 to 2019

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

Get 2MM+ Premium Access

Recent Reports

#VisualAbstract: Chemoradiotherapy plus surgery improves 10-year overall survival compared to surgery alone in esophageal cancer

RELATED REPORTS

#VisualAbstract Ibrutinib may be beneficial in heavily pretreated patients with classic and variant hairy cell leukemia

Transglutaminase 2 inhibition attenuates mucosal injury in patients with celiac disease

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

Get 2MM+ Premium Access

Recent Reports